Emily Finnessy is a Owings Mills, Maryland based physiatrist who is specialized in Sports Medicine (PM&R). Active license number of Emily Finnessy as Sports Medicine (PM&R) is A0001678 in Maryland.
Emily Finnessy provides continuous care related to the enhancement of health and fitness as well as the prevention of injury and illness. The specialist possesses knowledge and experience in the promotion of wellness and the prevention of injury from many areas of medicine such as exercise physiology, biomechanics, nutrition, psychology, physical rehabilitation, epidemiology, physical evaluation and injuries. It is the goal of a Sports Medicine specialist to improve the healthcare of the individual engaged in physical exercise.
Complete Profile:
Emily Finnessy speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790591949
NPI Enumeration Date:
03 Dec, 2024
NPI Last Update On:
03 Dec, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Emily Finnessy are as mentioned below.
License Number
Specialization
State
Status
A0001678
Sports Medicine
Maryland
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
9907 Finney Dr, Parkville, Maryland
Zip:
21234-1807
Phone Number:
--
Fax Number:
--
Patients can reach Emily Finnessy at 100 Campus Cir, Owings Mills, Maryland or can call to book an appointment on 443-352-5691. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.